Recurrent bilateral cutaneous squamous cell carcinoma arising within hypertrophic lichen planus with metastasis while on cemiplimab

Melissa C Leeolou; Nareh Marukian Burgren; Carolyn S Lee; Arash Momeni; Harlan Pinto; Peter Johannet; Cara Liebert; Kristin M Nord; Anne Lynn S Chang

doi:10.1016/j.jdcr.2022.08.046

Recurrent bilateral cutaneous squamous cell carcinoma arising within hypertrophic lichen planus with metastasis while on cemiplimab

JAAD Case Rep. 2022 Sep 5:29:55-58. doi: 10.1016/j.jdcr.2022.08.046. eCollection 2022 Nov.

Authors

Melissa C Leeolou¹, Nareh Marukian Burgren¹, Carolyn S Lee^{1

2}, Arash Momeni³, Harlan Pinto⁴, Peter Johannet⁵, Cara Liebert⁵, Kristin M Nord^{1

2}, Anne Lynn S Chang¹

Affiliations

¹ Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
² Department of Dermatology, Veterans Administration Palo Alto Healthcare System, Palo Alto, California.
³ Department of Surgery (Plastic and Reconstructive), Stanford University School of Medicine, Palo Alto, California.
⁴ Department of Oncology, Veterans Administration Palo Alto Healthcare System, Palo Alto, California.
⁵ Surgical Service, Plastic Surgery Section, Veterans Administration Palo Alto Health Care System, Palo Alto, California.

No abstract available

Keywords: CSCC, cutaneous squamous cell carcinoma; HLP, hypertrophic lichen planus; KC, keratinocytic cancer; LN, lymph node; PD, programmed death; PD-1; PD-1 inhibitor; cutaneous immune-related adverse event; cutaneous toxicity; hypertrophic lichen planus; hyponatremia; lichen planus; lichenoid; lymph node; metastasis; programmed death-1; squamous cell carcinoma; treatment.

Publication types

Case Reports